LT4182B - Remedy for treatment of ovarian estrogen dependent conditions - Google Patents
Remedy for treatment of ovarian estrogen dependent conditions Download PDFInfo
- Publication number
- LT4182B LT4182B LT96-133A LT96133A LT4182B LT 4182 B LT4182 B LT 4182B LT 96133 A LT96133 A LT 96133A LT 4182 B LT4182 B LT 4182B
- Authority
- LT
- Lithuania
- Prior art keywords
- antiprogestin
- gonadrotropin
- releasing hormone
- treatment
- endometriosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/191,631 US5681817A (en) | 1994-02-04 | 1994-02-04 | Treatment of ovarian estrogen dependent conditions |
Publications (2)
Publication Number | Publication Date |
---|---|
LT96133A LT96133A (en) | 1997-01-27 |
LT4182B true LT4182B (en) | 1997-06-25 |
Family
ID=22706258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LT96-133A LT4182B (en) | 1994-02-04 | 1996-09-04 | Remedy for treatment of ovarian estrogen dependent conditions |
Country Status (29)
Country | Link |
---|---|
US (1) | US5681817A (lv) |
EP (1) | EP0785792B1 (lv) |
JP (1) | JP3130048B2 (lv) |
KR (1) | KR970700507A (lv) |
CN (1) | CN1144486A (lv) |
AP (1) | AP724A (lv) |
AT (1) | ATE179610T1 (lv) |
AU (1) | AU689229B2 (lv) |
BG (1) | BG62238B1 (lv) |
BR (1) | BR9506606A (lv) |
CA (1) | CA2182183C (lv) |
CZ (1) | CZ291709B6 (lv) |
DE (1) | DE69509544T2 (lv) |
DK (1) | DK0785792T3 (lv) |
ES (1) | ES2132645T3 (lv) |
FI (1) | FI963036A (lv) |
GR (1) | GR3030164T3 (lv) |
HU (1) | HUT74622A (lv) |
LT (1) | LT4182B (lv) |
LV (1) | LV11782B (lv) |
MD (1) | MD1432C2 (lv) |
NZ (1) | NZ281441A (lv) |
OA (1) | OA10777A (lv) |
PL (1) | PL178273B1 (lv) |
RO (1) | RO117420B1 (lv) |
RU (1) | RU2110274C1 (lv) |
SK (1) | SK96296A3 (lv) |
TJ (1) | TJ242B (lv) |
WO (1) | WO1995020972A1 (lv) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0769956B1 (en) * | 1994-07-22 | 2000-03-15 | The Medical College Of Hampton Roads | USE OF A GnRH ANTAGONIST FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GONADAL-STEROID CONDITIONS |
US5780435A (en) * | 1995-12-15 | 1998-07-14 | Praecis Pharmaceuticals Incorporated | Methods for treating prostate cancer with LHRH-R antagonists |
CA2306110A1 (en) | 1997-10-17 | 1999-04-29 | Mochida Pharmaceutical Co., Ltd. | Therapeutic agent of uterine leiomyoma, containing dienogest as effective ingredient |
US6703367B1 (en) | 1999-04-27 | 2004-03-09 | Praecis Pharmaceuticals Inc. | Methods for treating hot flashes and gynaecomastia |
US6407101B1 (en) * | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
US6358947B1 (en) | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Tetracyclic progesterone receptor modulator compounds and methods |
US6380235B1 (en) | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Benzimidazolones and analogues |
US6423699B1 (en) | 1999-05-04 | 2002-07-23 | American Home Products Corporation | Combination therapies using benzimidazolones |
US6462032B1 (en) | 1999-05-04 | 2002-10-08 | Wyeth | Cyclic regimens utilizing indoline derivatives |
US6369056B1 (en) | 1999-05-04 | 2002-04-09 | American Home Products Corporation | Cyclic urea and cyclic amide derivatives |
US6339098B1 (en) | 1999-05-04 | 2002-01-15 | American Home Products Corporation | 2,1-benzisothiazoline 2,2-dioxides |
US6498154B1 (en) | 1999-05-04 | 2002-12-24 | Wyeth | Cyclic regimens using quinazolinone and benzoxazine derivatives |
US6417214B1 (en) | 1999-05-04 | 2002-07-09 | Wyeth | 3,3-substituted indoline derivatives |
US6306851B1 (en) | 1999-05-04 | 2001-10-23 | American Home Products Corporation | Cyclocarbamate and cyclic amide derivatives |
US6358948B1 (en) | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
US6319912B1 (en) | 1999-05-04 | 2001-11-20 | American Home Products Corporation | Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides |
US6399593B1 (en) | 1999-05-04 | 2002-06-04 | Wyeth | Cyclic regimens using cyclic urea and cyclic amide derivatives |
US6329416B1 (en) | 1999-05-04 | 2001-12-11 | American Home Products Corporation | Combination regimens using 3,3-substituted indoline derivatives |
US6509334B1 (en) | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
US6380178B1 (en) | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Cyclic regimens using cyclocarbamate and cyclic amide derivatives |
US6444668B1 (en) | 1999-05-04 | 2002-09-03 | Wyeth | Combination regimens using progesterone receptor modulators |
US6391907B1 (en) | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
US6355648B1 (en) * | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
BR0014161A (pt) * | 1999-08-31 | 2002-05-21 | Jenapharm Gmbh | Mesoprogestinas (moduladores de receptor de progesterona) no tratamento e prevenção de distúrbios ginecológicos dependentes de hormÈnio benigno |
US8193252B1 (en) | 1999-08-31 | 2012-06-05 | Bayer Pharma AG | Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders |
UA73119C2 (en) * | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
DE60113142T2 (de) * | 2000-10-30 | 2006-07-06 | University Of Zurich | Verwendung von gnrh-analogue zur behandlung der harninkontinenz |
US6960337B2 (en) * | 2002-08-02 | 2005-11-01 | Balance Pharmaceuticals, Inc. | Methods and compositions for treating benign gynecological disorders |
US6958142B2 (en) * | 2002-08-02 | 2005-10-25 | Balance Pharmaceuticals, Inc. | Nasal spray formulation and method |
US7029657B2 (en) * | 2002-08-02 | 2006-04-18 | Balance Pharmaceuticals, Inc. | Nasal spray steroid formulation and method |
GB0302572D0 (en) | 2003-02-05 | 2003-03-12 | Astrazeneca Ab | Method of treatment |
AU2006215300C9 (en) * | 2005-02-17 | 2010-05-06 | Hadasit Medical Research Services And Development Ltd. | Bisphosphonates for treating endometriosis |
US20060251581A1 (en) * | 2005-05-09 | 2006-11-09 | Mcintyre Jon T | Method for treatment of uterine fibroid tumors |
US7862552B2 (en) | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
TWI455716B (zh) * | 2006-10-24 | 2014-10-11 | Repros Therapeutics Inc | 選擇性黃體激素受體調節劑用於製造治療雌激素依賴性病症之藥物的用途 |
SI2078032T1 (sl) * | 2006-10-24 | 2017-12-29 | Repros Therapeutics Inc. | Sestave in postopki za zaviranje proliferacije endometrija |
US20080287408A1 (en) * | 2007-05-14 | 2008-11-20 | Drugtech Corporation | Endometriosis treatment |
ES2467942T3 (es) * | 2007-09-20 | 2014-06-13 | Lapidot Medical Import And Marketing Ltd | Composiciones y medios para tratar leiomiomas uterinos, leiomioma, mioma, fibroides uterinos, endometriosis, adenomiosis y trastornos relacionados por mifepristona. |
RU2359684C1 (ru) * | 2008-01-23 | 2009-06-27 | Закрытое акционерное общество "СКАЙ ЛТД" | Способ лечения эндометриоза |
US9993427B2 (en) | 2013-03-14 | 2018-06-12 | Biorest Ltd. | Liposome formulation and manufacture |
KR101585221B1 (ko) | 2014-02-27 | 2016-01-13 | 권희완 | 지압대 겸용 지압 베개 |
EP3560555A1 (en) | 2018-04-26 | 2019-10-30 | LifeArc | A composition for treating one or more estrogen related diseases |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4386085A (en) | 1981-01-09 | 1983-05-31 | Roussell Uclaf | Novel steroids |
US4609651A (en) | 1983-12-22 | 1986-09-02 | Schering Aktiengesellschaft | 11β-arylestradienes, their production, and pharmaceutical preparations containing same |
US4780461A (en) | 1983-06-15 | 1988-10-25 | Schering Aktiengesellschaft | 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same |
US4891368A (en) | 1987-12-21 | 1990-01-02 | Schering Aktiengesellschaft | Use of antigestagens for softening the nonpregnant cervix |
US4957119A (en) | 1987-08-08 | 1990-09-18 | Akzo N.V. | Contraceptive implant |
EP0404283A2 (de) | 1989-06-23 | 1990-12-27 | Schering Aktiengesellschaft | 11-Beta-aryl-4-estrene, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
WO1991014704A2 (en) | 1990-03-16 | 1991-10-03 | Applied Research Systems Ars Holding N.V. | Treatment of polycystic ovarian disease |
US6827050B2 (en) | 2001-12-21 | 2004-12-07 | Caterpillar Inc | Fluid control valve actuating system |
US7283632B2 (en) | 2003-09-09 | 2007-10-16 | The Boeing Company | Unauthorized access embedded software protection system |
-
1994
- 1994-02-04 US US08/191,631 patent/US5681817A/en not_active Expired - Fee Related
-
1995
- 1995-02-02 AP APAP/P/1996/000840A patent/AP724A/en active
- 1995-02-02 PL PL95315792A patent/PL178273B1/pl not_active IP Right Cessation
- 1995-02-02 MD MD96-0323A patent/MD1432C2/ro unknown
- 1995-02-02 RO RO96-01583A patent/RO117420B1/ro unknown
- 1995-02-02 EP EP95910179A patent/EP0785792B1/en not_active Expired - Lifetime
- 1995-02-02 RU RU96118109A patent/RU2110274C1/ru active
- 1995-02-02 SK SK962-96A patent/SK96296A3/sk unknown
- 1995-02-02 NZ NZ281441A patent/NZ281441A/en unknown
- 1995-02-02 JP JP07520794A patent/JP3130048B2/ja not_active Expired - Fee Related
- 1995-02-02 KR KR1019960704226A patent/KR970700507A/ko not_active Application Discontinuation
- 1995-02-02 TJ TJ96000402A patent/TJ242B/xx unknown
- 1995-02-02 HU HU9601969A patent/HUT74622A/hu unknown
- 1995-02-02 DK DK95910179T patent/DK0785792T3/da active
- 1995-02-02 CZ CZ19962103A patent/CZ291709B6/cs not_active IP Right Cessation
- 1995-02-02 CN CN95192252A patent/CN1144486A/zh active Pending
- 1995-02-02 AT AT95910179T patent/ATE179610T1/de not_active IP Right Cessation
- 1995-02-02 AU AU18386/95A patent/AU689229B2/en not_active Ceased
- 1995-02-02 WO PCT/US1995/001479 patent/WO1995020972A1/en active IP Right Grant
- 1995-02-02 CA CA002182183A patent/CA2182183C/en not_active Expired - Fee Related
- 1995-02-02 ES ES95910179T patent/ES2132645T3/es not_active Expired - Lifetime
- 1995-02-02 BR BR9506606A patent/BR9506606A/pt not_active Application Discontinuation
- 1995-02-02 DE DE69509544T patent/DE69509544T2/de not_active Expired - Fee Related
-
1996
- 1996-07-29 OA OA60870A patent/OA10777A/en unknown
- 1996-08-01 BG BG100766A patent/BG62238B1/bg unknown
- 1996-08-01 FI FI963036A patent/FI963036A/fi not_active IP Right Cessation
- 1996-09-03 LV LVP-96-354A patent/LV11782B/en unknown
- 1996-09-04 LT LT96-133A patent/LT4182B/lt not_active IP Right Cessation
-
1999
- 1999-05-07 GR GR990401145T patent/GR3030164T3/el unknown
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4386085A (en) | 1981-01-09 | 1983-05-31 | Roussell Uclaf | Novel steroids |
US4780461A (en) | 1983-06-15 | 1988-10-25 | Schering Aktiengesellschaft | 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same |
US4609651A (en) | 1983-12-22 | 1986-09-02 | Schering Aktiengesellschaft | 11β-arylestradienes, their production, and pharmaceutical preparations containing same |
US4957119A (en) | 1987-08-08 | 1990-09-18 | Akzo N.V. | Contraceptive implant |
US5088505A (en) | 1987-08-08 | 1992-02-18 | Akzo N.V. | Contraceptive implant |
US4891368A (en) | 1987-12-21 | 1990-01-02 | Schering Aktiengesellschaft | Use of antigestagens for softening the nonpregnant cervix |
EP0404283A2 (de) | 1989-06-23 | 1990-12-27 | Schering Aktiengesellschaft | 11-Beta-aryl-4-estrene, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
WO1991014704A2 (en) | 1990-03-16 | 1991-10-03 | Applied Research Systems Ars Holding N.V. | Treatment of polycystic ovarian disease |
US6827050B2 (en) | 2001-12-21 | 2004-12-07 | Caterpillar Inc | Fluid control valve actuating system |
US7283632B2 (en) | 2003-09-09 | 2007-10-16 | The Boeing Company | Unauthorized access embedded software protection system |
Non-Patent Citations (3)
Title |
---|
CARR BR ET AL.: "An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.", J CLIN ENDOCRINOL METAB., 1993, pages 1217 - 1223 |
CHWALISZ, K. ET AL.: "Inhibition of the estradiol mediated endometrial gland formation by the anti-gestagen onapristone in rabbits: Relationship to uterine estrogen receptors", ENDOCRINOLOGY, 1991, pages 312 - 322 |
GOODMAN AND GILMAN: "The Pharmaceutical Basis of Therapeutics" |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LT4182B (en) | Remedy for treatment of ovarian estrogen dependent conditions | |
KR100385663B1 (ko) | 여성피임용으로함께사용될수있는프로게스테론길항작용및항에스트로겐작용이있는화합물 | |
JP3937240B2 (ja) | 黄体ホルモン関連の破綻出血の最小化 | |
EP2079461A1 (en) | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens | |
JPH01502265A (ja) | 避妊薬用としての性ステロイド放出と組合わされた黄体形成ホルモン放出ホルモン組成物の連続放出 | |
Jeppsson et al. | Short‐term effects of danazol on endometrial histology | |
RU2181598C2 (ru) | Восстановление тонической секреции эстрогена из яичников для продолжительных схем лечения | |
LT4341B (lt) | Toninės kiaušidžių estrogeno sekrecijos sureguliavimas pailgintiems terapiniams režimams | |
BG106442A (bg) | Мезопрогестини (прогестерон рецептор модулатори) за лечение и профилактика на хормонозависими доброкачествени гинекологични заболявания | |
US11376263B2 (en) | Cyproterone acetate compositions and uses thereof | |
DMOWSKI et al. | Zvi BINOR, lan TUMMON and Peg PEPPING Section of Reproductive Endocrinology/Infertility, Department of Obstetrics and Gynecology Rush Medical College, Chicago, Illinois 60612, USA | |
MXPA97004742A (es) | Compuestos con propiedades antagonistas de progesterona y anti-estrogeno para su uso combinado en la anticoncepcion femenina | |
AU2011203526A1 (en) | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM9A | Lapsed patents |
Effective date: 20010202 |